IGF1 and polycystic ovary syndrome: PCOS patients generally have insulin resistance, and IGF1 can enhance pancreatic β cell viability and inhibit apoptosis by activating the Sirt1/PI3K/Akt/FoxO1 pathway, inducing insulin secretion, and alleviating oxidative damage (Vinciguerra et al., 2009).